Schmid et al. [94] conducted a trial on SNPs in the coding region of MACC1 and the clinical outcome of CRC and discovered that SNP might be associated with a reduced survival for younger colon cancer patients in early stages. Here, MACC1 is linked to malignant colon neoplasm.